Summary
Boston Scientific Corporation (BSX) filed an 8-K on January 14, 2020, to announce preliminary, unaudited sales results for the fourth quarter and full year ended December 31, 2019. The filing primarily serves as a vehicle to disseminate this important sales update to investors ahead of their full financial report. While specific sales figures are detailed in the accompanying press release (Exhibit 99.1), this 8-K itself does not contain the detailed financial statements or management discussion and analysis typically found in a quarterly or annual report.
Key Highlights
- 1Boston Scientific announced preliminary sales results for Q4 and full year 2019 via an 8-K filing.
- 2The announcement was made on January 14, 2020, based on information as of January 13, 2020.
- 3The key information is contained within the attached press release (Exhibit 99.1).
- 4This filing focuses solely on sales results and does not include comprehensive financial statements or operational details.
- 5The information provided is preliminary and unaudited.
- 6This 8-K is an informational update rather than a detailed financial disclosure.
Frequently Asked Questions
The main purpose of this 8-K filing is to provide investors with preliminary, unaudited sales results for Boston Scientific's fourth quarter and full year ended December 31, 2019, which were announced via a press release.
The detailed sales figures are located in the press release issued by Boston Scientific Corporation dated January 14, 2020, which is attached as Exhibit 99.1 to this 8-K filing.
No, this 8-K filing is specifically an update on preliminary sales results and does not contain the full audited financial statements or management's discussion and analysis for the fourth quarter or full year 2019.
The information contained in Item 2.02 of this Current Report and Exhibit 99.1 is specifically stated as not being deemed 'filed' for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section. It is considered an update and announcement, not a formal filing of financial results.